Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Sandeep Randhawa (NPI 1841486172)

Field	Value
Entity Type	Individual
Organization	Sandeep Randhawa
Address	3555 W 13 Mile Rd
City	Royal Oak
State	MI
ZIP	48073
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	September 20, 2007

Payer Source	Total Paid
Medicare	$7M
Medicaid	$0

Key Findings

SANDEEP RANDHAWA’s Medicare billing profile is dominated by retina‑focused, office‑based care: the top revenue codes are J0178 (aflibercept injection), J2778 (ranibizumab injection), and 99214 (established outpatient E/M). High claim counts and payments for these codes — J0178 with 7.9K claims and $5.4M revenue, J2778 with 2.2K claims and $393.8K revenue, and 99214 with 4K claims and $376.6K revenue — indicate a practice model centered on frequent intravitreal anti‑VEGF therapy paired with routine follow‑up visits.

Revenue is highly concentrated: the precomputed top three codes (J0178, J2778, 99214) account for 88.5% of the provider’s total Medicare revenue. In particular, J0178 alone represents $5.4M or 77.5% of the provider’s $7M in Medicare revenue, signaling material dependency on a single high‑value drug code.

This provider is effectively a single‑payer operation from a billing perspective: total Medicare revenue is $7M while there is none for Medicaid (no Medicaid billing on file). That payer mix exposes the practice to Medicare reimbursement and utilization policy shifts without any Medicaid revenue diversification to mitigate downside.

On competitive standing, SANDEEP RANDHAWA is a national outlier for several high‑volume services: J0178 ranks #1 of 3204 providers nationally (100th percentile; extreme outlier), 99214 ranks #68 of 479517 (100th percentile; extreme outlier), and 67028 ranks #65 of 4255 (98th percentile; extreme outlier). By contrast, J2778 ranks #200 of 1208 (84th percentile; typical, unremarkable volume), indicating the provider is exceptionally dominant for aflibercept use and high‑volume E/M visits but more typical for ranibizumab.

Operational implications from the claims profile point to a high‑throughput injection workflow: 7.9K J0178 claims and an average paid/claim of $688 imply sustained scheduling, supply chain and staff capacity focused on frequent intravitreal injections. The presence of large E/M volume (4K claims for 99214) suggests bundled visit schedules where medical management and injections are co‑distributed rather than rare, isolated procedures.

The concentration on a costly biologic (J0178) creates both negotiating leverage and financial concentration risk: because $5.4M of the $7M Medicare revenue is tied to that single code, changes in formulary placement, reimbursement rates, or utilization controls for aflibercept could materially affect revenue. The lack of Medicaid billing means there is limited offset from alternate payer streams if Medicare revenue declines.

Clinical scope includes some surgical and diagnostic retina services beyond injections, but at much lower revenue levels: 67042 has $21.1K revenue, 67113 has $15.4K revenue, and 92134 imaging has $124.2K revenue. These figures indicate capacity for vitreoretinal procedures and retinal imaging consistent with a retina specialist practice, but those services are a modest fraction of total Medicare income compared with anti‑VEGF injections.

The provider has a long Medicare enrollment history (NPI enumerated 2007-09-20, ~19 years ago), which together with concentrated, high‑volume Medicare billing suggests an established, stable retinal practice in ROYAL OAK, MI. Analysts evaluating network partnerships or competitive positioning should view this as a mature, injection‑centric practice with pronounced exposure to Medicare policy and anti‑VEGF utilization trends.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	7,880	$690	$5.4M
J2778	Injection, ranibizumab, 0.1 mg	2,150	$180	$393.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	4,010	$90	$376.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,340	$110	$350.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,140	$30	$124.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,200	$30	$121.8K
J3590	Unclassified biologics	40	$1,200	$49.1K
J3490	Unclassified drugs	20	$1,790	$26.9K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$920	$21.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	120	$170	$19.2K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Sandeep Randhawa — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	110	680	$690	$630.2K
J2777	41	60	7,200	$30	$321K
J2778	14	50	730	$180	$240.5K
67028	1	160	440	$90	$57.6K
J3590	65	80	140	$80	$19.6K
67042	6	30	20	$1,030	$18.6K
67036	8	10	20	$910	$16.4K
67113	2	10	20	$1,010	$16.2K
92014	828	1,080	100	$80	$14.8K
99214	1	15,470	80	$80	$11.4K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Sandeep Randhawa, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Beaumont Hospital	MI	Hospitalist Physician	$0	$167.9M
Oakwood Healthcare, Inc.	MI	General Acute Care Hospital	$0	$165.3M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$162.4M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$84.8M
Oakwood Ambulatory LLC	MI	Internal Medicine Physician	$0	$66.9M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$61.5M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wellstreet Urgent Care Of Michigan	MI	Urgent Care Clinic/Center	$0	$37.5M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Associated Retinal Consultants, PC	MI	Ophthalmology Physician	$0	$21.1M

Nearby Providers

Other providers in the same ZIP code as Sandeep Randhawa, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Judson Center, Inc.	MI	Community/Behavioral Health Agency	$0	$21.2M
Allergy & Asthma Associates Of Mi PC	MI	Allergy & Immunology Physician	$0	$15.9M
Community Homes, Inc.	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$7.5M
American Anesthesiology Of Michigan PC	MI	Anesthesiology Physician	$0	$5.7M
Joshua Robinson	MI	Ophthalmology Physician	$3.7M	$0
Jeremy Wolfe	MI	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Tamer Mahmoud	MI	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
George Williams	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Kimberly Drenser	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Alan Ruby	MI	Ophthalmology Physician	$2.4M	$0

Sandeep Randhawa — Billing Profile & Reimbursement Data

Sign up for Sandeep Randhawa — Billing Profile & Reimbursement Data policy alerts

Sandeep Randhawa — Billing Profile & Reimbursement Data

Sign up for Sandeep Randhawa — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References